Verastem (VSTM)

[infamous]

its recovering nicely. next leg up coming

[realfast95]

Kevin_Wolcott
3m
$VSTM ORR % dropped compared to what they reported in April. That's why it's down

67% > 41%

[infamous]

im seem to be the only one watching, but this is bouncing off the 10EMA 1.27 nicely here for the next leg up which it needed to do IMO. VSTM

[infamous]

compelling op in small cell lung cancer too. VSTM

[infamous]

their cash in hand is GREAT too. anyone hearing this? VSTM

[infamous]

the CC is GOOD! very positive results. bought more pre market. this will be at 4.00 again soon IMO. VSTM

[Harbor6460]

Def little posters. Big money coming here. Price to book good. Pipeline coming. Could even buy a stage 1 and advance. Immu 30 years to get to market. 2.00 to 90 buyout. Sick

[infamous]

hahahahaha ok! im getting more here at 1.37 btw. new support IMO

[RiskyRewards]

Ahh mixed up the dates it’s tomorrow morning

[infamous]

didnt get a chance. you? VSTM

[RiskyRewards]

You tune in for the conference call?

[infamous]

im surprised almost no posters here! this is going back over 2.00 soon IMO. VSTM

[realfast95]

New Results Evaluating Combination of VS-6766 and Defactinib to be Presented at the 2nd Annual RAS-Targeted Drug Development Summit

Management to Host Investor Conference Call and Webcast on Wednesday, September 16 at 8:00 AM ET

[infamous]

IDK

[infamous]

IDK

[RiskyRewards]

Looks like today might be the day we reverse fingers

[DrHarleyboy]

They are fundamentally toast after the botched clinical findings release...will be lucky to stay above $1 at this point.

[infamous]

Nine biopharma CEOs pledge to make safety the main focus in coronavirus vaccine development

hopefully this news will spark bios!

[infamous]

wtf! is there ANYONE here interested in this thing anymore? VSTM

[infamous]

ahhh so quiet. buying more here at 1.27 for the push to 3.00 VSTM

[infamous]

this could be a serious indicator of a directional change. if this is above 1.30 by end of week(which i suspect for certain) this could be over 2.00 next IMO. VSTM

[infamous]

most likely a purchase

[realfast95]

someone traded 3,878,895 in a block trade at 1.17
earlier today, afternoon

[infamous]

if this is at 1.30 or higher by end of week, that would signal a hard turnaround. lets watch and see. VSTM

[DrHarleyboy]

Absolutely. I imagine they are dumping shares for this price decline.

[infamous]

IMO, its MM manipulation! I called IR. SS hasnt changed. Noone in the company is selling. Company just got a big cash infusion and will be settled mid Sept. This is a GOOD company . VSTM

[elcheepo]

someone is dumping shares.. why, no know.

[infamous]

im so taken back my this MM manipulation! this should be at 3.00! anyone?

[infamous]

this MM manipulation on this WAY oversold gem of a company is almost criminal. thoughts anyone? VSTM

[infamous]

no worries. i talked with IR this morning and love my investment now. were good! his name is bob doyle.

[elcheepo]

Yes, a real pizz off !!

[Tempy]

Man...this has been in free fall since end of April.

[infamous]

i talked to Bob Doyle IR/finance guy. I loved everything i heard about the amount of cash that they have, their unchanged SS , and their future cash infusion, and the fact that the only convertible debt they have is due all the way in 2022. VSTM

[infamous]

i analyzed this c9mpany. reading filings. looking at SS. look8ng at chart. THIS SHOULD BE A 7.00 STOCK!

[elcheepo]

that's what i been saying!

[infamous]

wtF is wrong with this stock? smfh

[infamous]

doesnt make sense. im bidding 16000 yet the bid only shows 15600 huh?

[infamous]

why would trump have ANYTHING to do w this little company!?

[realfast95]

long term yes.

All ears and eyes on Trump at 5:30pm

will they mention

Remdesivir + VS-6766
$GILD $VSTM

[infamous]

is that good for us?

[realfast95]

Details of the agreement with Secura Bio on August 10th
Perhaps this is why the the stock didn't move. The deal is spread out. They are burning 13m/Qtr or 52m/yr

Secura Bio has agreed to pay the Company an up-front payment of $70.0 million in cash payable at the closing of the Transaction

After the Closing regulatory milestone payments of $35.0 million upon receipt of regulatory approval of COPIKTRA in the United States for the treatment of peripheral T-cell lymphoma

Payent of $10.0 million upon receipt of the first regulatory approval for the commercial sale of COPIKTRA in the European Union for the treatment of peripheral T-cell lymphoma.

Sales milestone payments consisting of $10.0 million when total worldwide net sales of COPIKTRA exceed $100.0 million,

$15.0 million when total worldwide net sales of COPIKTRA exceed $200.0 million

$25.0 million when total worldwide net sales of COPIKTRA exceed $300.0 million,

low double-digit royalties on the annual aggregate net sales above $100.0 million in the United States and Europe

50% of all royalty, milestone and sublicense revenue payments payable to Secura Bio under the Company’s existing license agreements with Sanofi, Yakult Honsha Co., Ltd. and CSPC Pharmaceutical Group Limited, each of which will transfer to Secura Bio at the Closing.

50% of all royalty and milestone payments payable to Secura Bio under any license or sublicense agreement entered into by Secura Bio after the Closing in certain jurisdictions.

[realfast95]

with a lot of luck needed. Maybe this is what Trump will mention Sunday night.


Remdesivir + VS-6766
$GILD+$VSTM

[infamous]

THATS A GREAT THING RIGHT? VSTM

[realfast95]

None of the analysts have reported since the cash deal. They are supposed to be independent from the Finance Brokers part of their business. The Brokers sell stock for their clients. Since VSTM doesn't need cash until 2023, the brokers don't have any deals.

Selling COPIKTRA Franchise to Secura Bio in a Deal Totaling $311 Million, Plus Royalties. Verastem recently announced its entry into a definitive agreement to sell its global commercial and development rights to COPIKTRA in all oncology indications to Secura Bio, Inc. The transaction, which carries a total deal value of up to $311 million, plus royalties, will provide Verastem’s current programs with a cash runway until at least 2024

[infamous]

what do you mean?

[realfast95]

since they won't need to raise any more money from dilution, the analysts don't seem to care anymore

BTIG, LLC Robert Hazlett
Cantor Fitzgerald Alethia Young
H.C. Wainwright Swayampaukula Ramakanth, Ph.D.

[infamous]

yes. one HAS to believe this will be back in the $4.00 range IMO. VSTM

[Harbor6460]

We need news. They have something in the works im sure with all that money on balance sheet niw

[infamous]

i dont understand why this isnt trading $3.50 to $6.00 IMO. this is absurd!

[realfast95]

The news we are hoping for is in combination with $GILD product
Remdesivir. Unusual options for $GILD was just cited for next week expiration $69. So maybe, perhaps wishful, the news will be sent out next week.